Quality of life and costs of patients prior to colorectal surgery. (3rd March 2020)

• Record Type: Journal Article
• Authors: Pattamatta, M.; Smeets, B. J. J.; Evers, S. M. A. A.; Peters, E. G.; Luyer, M. D. P.; Hiligsmann, M.
• Is Part Of: Expert review of pharmacoeconomics & outcomes research. Volume 20:Number 2(2020)
• Page Start: 193
• Page End: 198
• Publication Date: 2020-03-03
• Subjects: Colorectal cancer -- costs -- quality of life -- Netherlands; Pharmacology -- Economic aspects -- Periodicals; 338.47615105
• DOI: 10.1080/14737167.2019.1628641
• Languages: English
• ISSNs: 1473-7167

Abstract

ABSTRACT: Objective : To assess the quality of life and societal costs of patients prior to colorectal surgery in the Netherlands. Methods : This study is embedded in a previous randomized controlled trial (SANICS II). The quality of life was measured using EQ-5D-5L questionnaires. The iMTA medical consumption questionnaire (iMCQ) and the iMTA productivity costs questionnaire (iPCQ) were used to identify and measure healthcare and productivity costs. Subgroup analyses were performed based on age and gender. Results : A total of 178 patients were included in the cost analysis and a total of 161 patients in the quality of life analysis. The three-month mean societal cost per patient amounted to €3, 211 of which €1, 459 was due to productivity losses. The mean utility was 0.88 per patient. Gender was an important predictor in quality of life with men scoring significantly higher than women (0.92 versus 0.82) at p < 0.0001. Conclusion : Colorectal cancer represents a high economic burden in the Netherlands. Further research with repeated cost and quality of life measurements would be needed to explore the change over time and the effects of surgery.